UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Investigational hypoxia-activated prodrugs: Making sense of future development Journal article
Current Drug Targets, 2019,Volume: 20,Issue: 6,Page: 668-678
Authors:  Su,Min Xia;  Zhang,Le Le;  Huang,Zhang Jian;  Shi,Jia Jie;  Lu,Jin Jian
Favorite |  | TC[WOS]:2 TC[Scopus]:3 | Submit date:2021/03/02
Dna alkylating agents  Hypoxia-activated prodrug  Patient selection  Reductase activity  Targeted drugs  Topoisomerase II inhibitors  
Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy Journal article
SMALL, 2018,Volume: 15,Issue: 4
Authors:  Zhimei He;  Yunlu Dai;  Xiangli Li;  Dan Guo;  Yijing Liu;  Xiaolin Huang;  Jingjing Jiang;  Sheng Wang;  Guizhi Zhu;  Fuwu Zhang;  Lisen Lin;  Jun‐Jie Zhu;  Guocan Yu;  Xiaoyuan Chen
Favorite |  | TC[WOS]:49 TC[Scopus]:51 | Submit date:2020/05/13
Banoxantrone  Cascade Therapy  Hypoxia-activated Prodrugs  Nanoscale Metal-organic Frameworks  Photodynamic Therapy  
Investigational Hypoxia-Activated Prodrugs: Making Sense of Future Development Journal article
Current Drug Targets, 2018,Volume: 20
Authors:  Min-Xia Su;  Le-Le Zhang;  Zhang-Jian Huang;  Jia-Jie Shi;  Jin-Jian Lu
Favorite |  | TC[WOS]:0 TC[Scopus]:3 | Submit date:2019/01/14
Hypoxia-activated Prodrug  Topoisomerase Ii Inhibitors  Dna Alkylating Agents  Targeted Drugs  Reductases Activity  Patient Selection  Clinical Progress  
Hybrid Nanomedicine Fabricated from Photosensitizer‐Terminated Metal–Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia‐Activated Cascade Chemotherapy Journal article
small, 2018,Volume: 15,Issue: 4
Authors:  Zhimei He;  Yunlu Dai;  Xiangli Li;  Dan Guo;  Yijing Liu;  Xiaolin Huang;  Jingjing Jiang;  Sheng Wang;  Guizhi Zhu;  Fuwu Zhang;  Lisen Lin;  Jun‐Jie Zhu;  Guocan Yu;  Xiaoyuan Chen
Favorite |  | TC[WOS]:0 TC[Scopus]:51 | Submit date:2019/01/28
Banoxantrone  Cascade Therapy  Hypoxia‐activated Prodrugs  Nanoscale Metal–organic Frameworks  Photodynamic Therapy